Noema Pharma Ag
Clinical trials sponsored by Noema Pharma Ag, explained in plain language.
-
New hope for 'suicide disease': drug trial targets facial pain
Symptom relief OngoingThis study tests a daily drug called basimglurant in 166 adults with trigeminal neuralgia, a condition causing severe facial pain often called the 'suicide disease.' Participants have not gotten enough relief from their current pain medicines. The trial looks at whether the drug …
Phase: PHASE2, PHASE3 • Sponsor: Noema Pharma AG • Aim: Symptom relief
Last updated May 13, 2026 16:03 UTC
-
New pill aims to quiet tics in tourette syndrome
Symptom relief OngoingThis study tests an experimental drug called gemlapodect to see if it can safely reduce tics in people with Tourette syndrome. About 164 adults and teenagers with moderate to severe tics will take the drug or a placebo for 12 weeks. The main goal is to measure changes in tic seve…
Phase: PHASE2 • Sponsor: Noema Pharma AG • Aim: Symptom relief
Last updated May 11, 2026 20:53 UTC